LS180 Cells
USD 550.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Información general
| Descripción | LS180 is a human colon adenocarcinoma cell line established from the primary tumor of an adult female patient with moderately well-differentiated colon adenocarcinoma that had metastasized to the pericolic adipose tissue. The cells are epithelial in morphology, with an oval to polygonal shape and diameters ranging from 20 to 40 μm. They exhibit ultrastructural characteristics typical of normal colonic mucosal cells, including abundant microvilli-particularly prominent in secretory cells-and the presence of intracytoplasmic mucin vacuoles. These cells display hallmark features of neoplasia, including high levels of carcinoembryonic antigen (CEA) production and the ability to form tumors in both hamster cheek pouches and immunodeficient mice, indicating their tumorigenic potential in vivo. LS180 cells were notable for their exceptionally high levels of CEA production, releasing approximately 900 times more CEA per cell into the culture medium and carrying 30 times more cell-associated CEA than other colon cancer lines such as HT-29. This makes LS180 a valuable model for studying the biochemical, immunological, and functional properties of neoplastic colonic epithelium, particularly in relation to CEA-associated tumor markers. The cells have been karyotyped and confirmed to have abnormal chromosomal complements consistent with neoplastic transformation. Their epithelial identity and tumor-associated traits make them suitable for use in immunological assays, drug screening, and studies on colorectal cancer biology and therapeutic response. Additionally, LS180 is part of the Cancer Cell Line Encyclopedia (CCLE), where it has been deeply characterized through multi-omics profiling including proteomics, transcriptomics, and mutation data. LS180 is classified as a microsatellite instable (MSI) cell line, a phenotype associated with a hypermutated genome and known to affect proteome organization and therapeutic vulnerabilities. The proteomic analysis of LS180 revealed that MSI cell lines, including LS180, exhibit significant dysregulation of protein complexes involved in mutation surveillance and translational control, offering insights into mechanisms of drug sensitivity and resistance. The proteomic data further support that large-scale pathway-level coordination in protein expression in LS180 is decoupled from RNA expression, underscoring the importance of direct protein-level investigations. |
|---|---|
| Organismo | Human |
| Tejido | Colon |
| Enfermedad | Adenocarcinoma |
| Sinónimos | LS-180, LS 180, Laboratory of Surgery 180 |
Características
| Edad | 58 years |
|---|---|
| Género | Female |
| Origen étnico | Caucasian |
| Tipo de célula | Epithelial cell of colon |
| Propiedades de crecimiento | Adherent |
Datos normativos
| Referencia | LS180 (Cytion catalog number 305823) |
|---|---|
| Nivel de bioseguridad | 1 |
| NCBI_TaxID | 9606 |
| N.º de acceso de Cellosaurus | CVCL_0397 |
Datos biomoleculares
| Expresión de antígenos | Serologically defined colon cancer antigen 3; Homo sapiens, expressed HLA A2, B13, B50; Blood type O |
|---|---|
| Isoenzimas | ADA, 1 ES-D, 1 G6PD, B PEP-D, 1 PGD, A PGM1, 1 PGM3, 2 |
| Tumorigénico | Yes; Yes, in nude mice |
| Perfil mutacional | Mutation: ACVR2A, Simple, p.Lys437Argfs*5 (c.1310delA), Homozygous, Mutation, CTNNB1, Simple, p.Ser45Phe (c.134C>T), Homozygous, KRAS, Simple, p.Gly12Asp (c.35G>A), Heterozygous. Mutation, PIK3CA, Simple, p.His1047Arg (c.3140A>G), Unspecified Mutation, TGFBR2, Simple, p.Lys128Serfs*35 (c.383delA), Homozygous; Mutation, TP53 |
| Cariotipo | Modal number = 45; range = 42 to 47. |
Manejo
| Medio de cultivo | EMEM (MEM Eagle), w: 2 mM L-Glutamine, w: 2.2 g/L NaHCO3, w: EBSS (Cytion article number 820100a) |
|---|---|
| Suplementos | Supplement the medium with 10% FBS |
| Reactivo de disociación | Accutase |
| Tiempo de duplicación | 72 hours |
| Medio de congelación | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Descongelación y cultivo de células |
|
| Atmósfera de incubación | 37°C, 5% CO2, humidified atmosphere. |
| Condiciones de envío | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Condiciones de almacenamiento | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Control de calidad y análisis molecular
| Esterilidad | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificado de análisis (CoA)
| Número de lote | Tipo de certificado | Fecha | Número de catálogo |
|---|---|---|---|
| 305823-291025 | Certificado de análisis | 05. Dec. 2025 | 305823 |